ROUTE    CONTACT
zoeken
FOLLOW US:
Investors
Investors

Cavadis is a young biomedical company active in the field of cardiovascular risk assessment. The company specializes in the discovery of novel biomarkers and the development of prognostic test to identify patient at risk for heart attacks and strokes. If you are evaluating Cavadis as a potential investment opportunity and you require more information, please contact us at contactus@cavadis.com.

Bookmark and Share
The Erasmus MC Biomedical Fund is an independent venture capital fund focusing on early stage companies and (university) spin-outs in the biotechnology and biomedical field with a presence in the Rotterdam region and beyond.
Read more
Thuja Capital is structured to invest in early stage healthcare (life science) innovations with a focus on biotechnology and medical devices. Thuja Capital is the manager of Thuja Capital Healthcare Fund, a venture capital fund dedicated to life science investments. Thuja Capital Healthcare Fund will specificaily invest in Benelux based start-up and early-stage life science companies.
Read more
The Utrecht Holdings unite Universiteit Utrecht Holding B.V. and UMC Utrecht Holding B.V. each of which are full subsidiaries of the Utrecht University and UMC Utrecht respectively. They share a common board of directors and are responsible for the successful commercial exploitation of the patent portfolio.
Read more
Related items
News
Get the latest insights in the business and research of CAVΛDIS™.

read more
Press Releases
Get up to date with the latest press releases from CAVΛDIS™.

read more